SOTERA HEALTH COMPANY (SHC)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SHC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SHC | Director | 42 | ["Managing partner at Warburg Pincus","Experience at Carlyle Group in the U.S. Buyout Fund","Experience in investment banking at Citigroup Inc.","Board member of several private healthcare companies","B.S. in economics and computer science from Duke University","M.B.A. from Harvard Business School","Extensive knowledge of strategy and business development in the healthcare sector","Wide-ranging experience as a director","Deep familiarity with the Company"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Ruoxi Chen, Age 42, has served as a member of our Board since 2020. Mr. Chen is a member of the Nominating and Corporate Governance Committee and the Nordion Pricing Committee. He received cash compensation of $77,500 and stock awards valued at $234,558 in 2025, for total compensation of $312,058.